01501 INT MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.05X | Oper Margin | 25.4% |
|---|---|---|---|
| LT Debt/Equity | 0.9% | Net Margin | 21.2% |
| Total Debt/Equity | 13.7% | Return on Equity | 10.2% |
| Price/Book | 2.19X | Return on Assets | 8.0% |
| (HKD 23.450) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 192.41 | 167.40 | 147.68 | 174.85 | 144.02 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +14.9 | +13.4 | -15.5 | +21.4 | +29.3 |
| Earnings Per Share (HKD) | 1.17 | 1.009 | 0.89 | 1.053 | 0.868 |
| Earnings Per Share Growth (%) | +15.9 | +13.5 | -15.5 | +21.4 | -1.3 |
| Dividend Per Share (HKD) | No dividend | 0.300 | 0.270 | 0.320 | 0.341 |
| P/E* (X) | 20.05 | 23.23 | 26.36 | 22.26 | 27.03 |
| Yield (%) | N/A | 1.28 | 1.15 | 1.36 | 1.45 |
| Dividend Share (%) | N/A | 29.72 | 30.35 | 30.38 | 39.30 |
| Book NAV (HKD) | 10.721 | 10.630 | 10.091 | 10.282 | 9.335 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 851.954 | 752.836 | +13.2 | 585.883 |
| Operating Result | 213.779 | 175.128 | +22.1 | 144.468 |
| Associates | -0.395 | 0 | N/A | 0 |
| Profit Before Taxation | 213.384 | 175.128 | +21.8 | 144.468 |
| Taxation | 23.335 | 21.9 | +6.6 | 10.635 |
| Profit /( Loss) After Taxation | 190.049 | 153.228 | +24.0 | 133.833 |
| Minority Interests | -1.865 | -3.229 | -42.2 | 2.12 |
| Net Profit | 180.917 | 151.882 | +19.1 | 131.713 |
| Earnings Per Share () | 1.1696 | 1.0093 | +15.9 | 0.8896 |
| Dividend Per Share () | 0.0000 | 0.3000 | -100.0 | 0.2700 |
| Announcement Date | 2025-03-18 | 2024-03-18 | NA | 2023-03-20 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
